Pediatric Fungal Network STudy of Rare Invasive Fungal DisEases in Immunocompromised Pediatric Patients |  |
Changing the world for pediatric invasive fungal diseases, infections caused by fungi that are present throughout everyday life, impacting individuals with weakened immune systems. | |
Principal Investigators
Children's Hospital of Philadelphia
THE
NUMBERS
What was your consortium's most significant achievement from the past year?
Brian T. Fisher, DO, MPH, MSCE, Principal Investigator, PFN-STRIDE: We were invited to present two talks at the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) Workshop on rare invasive mold diseases. The workshop was held on August 13–14, 2026.
EARLY CAREER INVESTIGATOR SPOTLIGHT
What are your research goals?
Dr. Otto: My research is based on the hypothesis that infections in immunocompromised children arise from identifiable clinical, microbial, and host-microbiome risk factors. I aim to leverage large-scale clinical data to better characterize the epidemiology of these infections and develop dynamic prediction models that incorporate changes in a patient's clinical course over time. Ultimately, this work is intended to support targeted infection-prevention strategies and more judicious use of antimicrobial and antifungal therapies in this vulnerable population.
Patient Impact Story
